Award Program Details
What We Fund
The Harrington Scholar-Innovator Award selection committee seeks breakthrough discovery defined by innovation, creativity, and potential clinical impact including:
- Discoveries deemed to address unmet medical needs
- Novel targets
- Potential to be developed into a commercial program.
- Possess intellectual property (IP) or protection strategy
- May be either a small molecule or biologic
- Diagnostics or devices only acceptable as part of a therapeutic development project or if completely transformative
Applicant Eligibility Requirements
To be eligible for the award, an applicant must meet the following requirements:
- Hold an MD, MD/PhD
- Hold a faculty position at an accredited academic medical center, university or research institution in the US and conduct the majority of his/her research activities at that institution
- A project may have only a single PI who is responsible for project oversight and financial management. The PI may engage collaborators, core labs, or commercial CROs to execute any fraction of the project
- Past recipients of Harrington Scholar-Innovator awards may submit new and distinct proposals but may not seek additional support for previously funded projects
Application Submission and Selection Process
- Interested applicants are required to submit a Letter of Intent by Wednesday, April 5, 2017 at 11:59 PM (Midnight), Eastern Daylight Time.
- The Harrington Discovery Institute will select projects that:
- Represent the highest quality science
- Demonstrate a highly innovative approach
- Have the greatest clinical potential
- Address unmet needs
- Up to 12 Harrington Scholar-Innovators will be selected and announced in December.
Submissions will be completed online at HarringtonDiscovery.SmartSimple.com.
Download our Guidelines [PDF]
Late submissions will not be accepted for any reason other than issues with the Harrington Discovery Institute’s submission system. Proposals received by Harrington Discovery Institute after the deadline will not be reviewed.